1 / 12

Acellular Therapy Market - Strategies and Applications

Acellular Therapy Market market to grow at a significant CAGR. Acellular Therapy Market market report by BIS Research provides deep market insight, industry analysis, trends.<br>

bisreports
Download Presentation

Acellular Therapy Market - Strategies and Applications

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Acellular Therapy Market - Strategies and Applications Table of Content GLOBAL ACELLULAR THERAPY MARKET – STRATEGIES AND APPLICATIONS Focus on Application, Pipeline, and Competitive Landscape March 2022 1 All rights reserved at BIS Research Inc.

  2. BIS Research is a leading market intelligence and technology research company. BIS Research publishes in- depth market intelligence reports focusing on the market estimations, technology analysis, emerging high- growth applications, deeply segmented granular country-level market data and other important market parameters useful in the strategic decision making for senior management. BIS Research provides multi-client reports, company profiles, databases, and custom research services. GLOBAL ACELLULAR THERAPY MARKET – STRATEGIES AND APPLICATIONS Copyright © 2022 BIS Research Inc. All Rights Reserved. This document contains highly confidential information and is the sole property of BIS Research. Disclosing, copying, circulating, quoting, or otherwise reproducing any or all contents of this document is strictly prohibited. Access to this information is provided exclusively for the benefit of the people or organization concerned. It may not be accessed by or offered whether for sale or otherwise to any third party. 2 All rights reserved at BIS Research Inc.

  3. Table of Content Executive Summary .......................................................................... 13 1.Global Acellular Therapy Market: Strategic Overview ................ 19 1.1 Acellular Therapy: Overview ........................................................................... 20 1.2 Stem Cell Therapy ........................................................................................... 20 1.2.1 Extracellular Vesicles .................................................................................... 22 1.2.2 Cell-Free Therapy with Extracellular Vesicles ............................................. 23 1.3 Cell Therapy vs. Cell-Free Therapy ................................................................ 23 1.3.1 Advantages of Cell Therapy and Cell-Free Therapy ................................... 24 1.3.2 Risks and Limitations of Cell Therapy and Cell-Free Therapy .................. 25 1.3.2.1 Challenges and Risks Associated with Stem Cell-Based Therapy in Regenerative Medicine ............................................................................... 25 1.3.2.2 Challenges and Risks Associated with Cell-Free Therapies: ..................... 26 1.4 Application of Extracellular Vesicles (EVs) in Regenerative Medicine ....... 27 1.4.1.1 Cardiology .................................................................................................. 27 GLOBAL ACELLULAR THERAPY MARKET – STRATEGIES AND APPLICATIONS 1.4.1.2 Hepatology ................................................................................................. 28 1.4.1.3 Neurology ................................................................................................... 29 1.4.1.4 Gastroenterology ........................................................................................ 29 1.4.1.5 Oncology .................................................................................................... 30 1.5 Acellular Therapy: A Novel Approach for COVID-19 .................................... 31 1.5.1 COVID-19 Therapeutic Strategies Involving the MSC Secretome ............. 31 1.5.2 Extracellular Vesicles Used in COVID-19 for Several Reasons ................. 32 1.6 Expert Insights ................................................................................................. 33 1.7 Clinical Trial Analysis: Acellular Therapy ...................................................... 34 1.7.1 Acellular Therapy Pipeline Analysis ............................................................. 35 1.7.2 Acellular Therapy Clinical Trial Design ........................................................ 38 1.7.2.1 ExoFlo ........................................................................................................ 38 1.7.2.1.1Product Profile .......................................................................................................... 38 1.7.2.1.2ExoFlo Phase II Study Design ................................................................................. 39 1.8 Extracellular Vesicles-Based Therapeutics: Regulatory Aspects ............... 43 1.8.1 Regulatory Frameworks in the U.S. .............................................................. 44 3 All rights reserved at BIS Research Inc.

  4. 1.8.2 Regulatory Frameworks in Europe ............................................................... 45 1.8.3 Regulatory Frameworks in Canada .............................................................. 46 1.8.4 Regulatory Frameworks in Japan ................................................................. 46 1.8.5 Regulatory Frameworks in Australia ............................................................ 47 1.8.6 Regulatory Frameworks in South Korea ...................................................... 47 1.8.7 Challenges Prior to Clinical Translation ...................................................... 48 1.9 Competitive Landscape .................................................................................. 48 1.9.1 Clinical Developments ................................................................................... 49 1.9.2 Regulatory and Legal Activities .................................................................... 50 1.9.3 Partnerships and Alliances ........................................................................... 51 1.9.4 Funding Activities .......................................................................................... 52 1.9.5 Business Expansions .................................................................................... 53 1.10Company Profiles ............................................................................................ 54 1.10.1 Overview ......................................................................................................... 54 1.10.2 Aegle Therapeutics Corp ............................................................................... 54 1.10.2.1 Company Overview .................................................................................... 54 GLOBAL ACELLULAR THERAPY MARKET – STRATEGIES AND APPLICATIONS 1.10.2.2 Role of Aegle Therapeutics Corp in the Acellular Therapy Market ............ 54 1.10.2.3 Business Strategies .................................................................................... 55 1.10.2.4 SWOT Analysis .......................................................................................... 56 1.10.3 ArunA Biomedical .......................................................................................... 57 1.10.3.1 Company Overview .................................................................................... 57 1.10.3.2 Role of ArunA Biomedical in the Acellular Therapy Market ........................ 57 1.10.3.3 Business Strategies .................................................................................... 57 1.10.3.4 SWOT Analysis .......................................................................................... 58 1.10.4 Capricor Therapeutics, Inc. ........................................................................... 59 1.10.4.1 Company Overview .................................................................................... 59 1.10.4.2 Role of Capricor Therapeutics, Inc. in the Acellular Therapy Market ......... 59 1.10.4.3 Business Strategies .................................................................................... 60 1.10.4.4 SWOT Analysis .......................................................................................... 60 1.10.5 Codiak BioSciences, Inc. ............................................................................... 61 1.10.5.1 Company Overview .................................................................................... 61 1.10.5.2 Role of Codiak BioSciences, Inc. in the Acellular Therapy Market ............ 61 4 All rights reserved at BIS Research Inc.

  5. 1.10.5.3 Financials ................................................................................................... 62 1.10.5.4 Key Insights About Financial Health of the Company ................................ 62 1.10.5.5 Business Strategies .................................................................................... 63 1.10.5.6 SWOT Analysis .......................................................................................... 64 1.10.6 Direct Biologics, LLC ..................................................................................... 65 1.10.6.1 Company Overview .................................................................................... 65 1.10.6.2 Role of Direct Biologics, LLC in the Acellular Therapy Market ................... 65 1.10.6.3 Business Strategies .................................................................................... 65 1.10.6.4 SWOT Analysis .......................................................................................... 66 1.10.7 EV Therapeutics, Inc. ..................................................................................... 67 1.10.7.1 Company Overview .................................................................................... 67 1.10.7.2 Role of EV Therapeutics in the Acellular Therapy Market .......................... 67 1.10.7.3 SWOT Analysis .......................................................................................... 68 1.10.8 Evox Therapeutics Ltd ................................................................................... 69 1.10.8.1 Company Overview .................................................................................... 69 1.10.8.2 Role of Evox Therapeutics Ltd in the Acellular Therapy Market ................ 69 GLOBAL ACELLULAR THERAPY MARKET – STRATEGIES AND APPLICATIONS 1.10.8.3 Business Strategies .................................................................................... 70 1.10.8.4 SWOT Analysis .......................................................................................... 71 1.10.9 Exogenus Therapeutics ................................................................................. 72 1.10.9.1 Company Overview .................................................................................... 72 1.10.9.2 Role of Exogenus Therapeutics in the Acellular Therapy Market .............. 72 1.10.9.3 Business Strategies .................................................................................... 72 1.10.9.4 SWOT Analysis .......................................................................................... 73 1.10.10 Invitrx Therapeutics, Inc. ............................................................................... 74 1.10.10.1 Company Overview .................................................................................... 74 1.10.10.2 Role of Invitrx Therapeutics, Inc. in the Acellular Therapy Market ............. 74 1.10.10.3 SWOT Analysis .......................................................................................... 75 1.10.11 Organicell Regenerative Medicine, Inc. ........................................................ 76 1.10.11.1 Company Overview .................................................................................... 76 1.10.11.2 Role of Organicell Regenerative Medicine, Inc. in the Acellular Therapy Market .......................................................................................... 76 1.10.11.3 Business Strategies .................................................................................... 77 1.10.11.4 SWOT Analysis .......................................................................................... 78 5 All rights reserved at BIS Research Inc.

  6. 1.10.12 Rion LLC ......................................................................................................... 79 1.10.12.1 Company Overview .................................................................................... 79 1.10.12.2 Role of Rion LLC in the Acellular Therapy Market ..................................... 79 1.10.12.3 SWOT Analysis .......................................................................................... 80 1.10.13 Stem Cell Medicine Ltd. ................................................................................. 81 1.10.13.1 Company Overview .................................................................................... 81 1.10.13.2 Role of Stem Cell Medicine Ltd. in the Acellular Therapy Market .............. 81 1.10.13.3 Business Strategies .................................................................................... 82 1.10.13.4 SWOT Analysis .......................................................................................... 82 GLOBAL ACELLULAR THERAPY MARKET – STRATEGIES AND APPLICATIONS 6 All rights reserved at BIS Research Inc.

  7. List of Figures Figure 1:Count of Published Research Papers for Acellular, Cell-Free, and Exosome-Based Therapy (Since 2015) Figure 2:Count of Clinical Trial for Cell-Free or Exosome-Based Therapies (as of March 2022) Figure 3:Global Acellular Therapy Market: Segmentation Figure 4:Function of Mesenchymal Stem Cells (MSCs) Figure 5:Hierarchy of Cell-Based and Cell-Free Therapy Figure 6:Three Major Classes of Extracellular Vesicles (EVs) Figure 7:Advantages of Cell-Based and Cell-Free Therapy Figure 8:Risk Factors with Stem Cell Therapy (SCT) Figure 9:Clinical Risks with Stem Cell Therapy (SCT) Figure 10:Extracellular Vesicles (EVs): Potential Therapeutic Tool for Several Disease Areas Figure 11:Properties of Mesenchymal Stem Cells (MSCs) Secretome Figure 12:Advantages, Challenges, and Clinical Applications of Cell-Based and Cell-Free Therapy Figure 13:Number of Clinical Trials by Academic Institutions and Biopharmaceutical Companies Figure 14:Acellular Drugs Clinical Trials (by Phase), 2022 Figure 15:Acellular Drugs Global Clinical Trials (by Indication), 2022 Figure 16:ExoFlo Phase II Clinical Trial Design for COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS) GLOBAL ACELLULAR THERAPY MARKET – STRATEGIES AND APPLICATIONS Figure 17:ExoFlo Phase II Clinical Trial Arms and Interventions for COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS) Figure 18:ExoFlo Phase II Clinical Trial Design for Mild-to-Moderate COVID-19 Figure 19:ExoFlo Phase II Clinical Trial Arms and Interventions for Mild-to-Moderate COVID-19 Figure 20:Three Factors Determine the Regulatory Status of hMSC-Based Products Figure 21:Challenges Prior to Clinical Translation Figure 22:Share of Key Developments and Strategies, January 2018-March 2022 Figure 23:Share of Clinical Developments (by Company), January 2018-March 2022 Figure 24:Share of Regulatory and Legal Activities (by Company), January 2018-March 2022 Figure 25:Share of Partnerships and Alliances (by Company), January 2018-March 2022 Figure 26:Share of Funding Activities (by Company), January 2018-March 2022 Figure 27:Share of Business Expansions (by Company), January 2018-March 2022 Figure 28:Aegle Therapeutics Corp: Product Portfolio Figure 29:Aegle Therapeutics Corp: SWOT Analysis Figure 30:ArunA Biomedical: Product Portfolio Figure 31:ArunA Biomedical: SWOT Analysis Figure 32:Capricor Therapeutics, Inc.: Product Portfolio Figure 33:Capricor Therapeutics, Inc.: SWOT Analysis Figure 34:Codiak BioSciences Inc.: Product Portfolio 7 All rights reserved at BIS Research Inc.

  8. Figure 35:Codiak BioSciences, Inc.: Overall Financials/Revenue, $Million, 2019-2021 Figure 36:Codiak BioSciences, Inc.: R&D Expenditure, $Million, 2019-2021 Figure 37:Codiak BioSciences, Inc.: R&D Expenditure (by Product), $Million, 2019-2021 Figure 38:Codiak BioSciences, Inc.: SWOT Analysis Figure 39:Direct Biologics, LLC: Product Portfolio Figure 40:Direct Biologics, LLC: SWOT Analysis Figure 41:EV Therapeutics, Inc.: Product Portfolio Figure 42:EV Therapeutics, Inc.: SWOT Analysis Figure 43:Evox Therapeutics Ltd: Product Portfolio Figure 44:Evox Therapeutics Ltd: SWOT Analysis Figure 45:Exogenus Therapeutics: Product Portfolio Figure 46:Exogenus Therapeutics: SWOT Analysis Figure 47:Invitrx Therapeutics, Inc.: Product Portfolio Figure 48:Invitrx Therapeutics, Inc.: SWOT Analysis Figure 49:Organicell Regenerative Medicine, Inc.: Product Portfolio Figure 50:Organicell Regenerative Medicine, Inc.: SWOT Analysis Figure 51:Rion LLC: Product Portfolio Figure 52:Rion LLC: SWOT Analysis Figure 53:Stem Cell Medicine Ltd.: Product Portfolio GLOBAL ACELLULAR THERAPY MARKET – STRATEGIES AND APPLICATIONS Figure 54:Stem Cell Medicine Ltd.: SWOT Analysis 8 All rights reserved at BIS Research Inc.

  9. List of Tables Table 1: Cell Therapies Vs. Cell-Free Therapies Table 2: Emerging Acellular Drugs Pipeline Table 3: Regulatory Proteins in ExoFlo GLOBAL ACELLULAR THERAPY MARKET – STRATEGIES AND APPLICATIONS 9 All rights reserved at BIS Research Inc.

  10. BIS Research Offerings: We are on a mission to harness the potential of disruptive technologies to make businesses thrive in today’s digital age. We have a vision to be a leading and a preferred knowledge partner for corporates and institutions worldwide and assist them with market intelligence in the area of emerging technologies, advisories, and other innovative solutions. GLOBAL ACELLULAR THERAPY MARKET – STRATEGIES AND APPLICATIONS Know More Know More Know More Know More 10 All rights reserved at BIS Research Inc.

  11. Disclaimer BIS Research Inc. provides valuable market intelligence to an exclusive group of customers in response to orders. The report is licensed for the customer's internal use only and is subject to restrictions set henceforth. This document and its contents are confidential and may not be further distributed, published or reproduced, in whole or in part, by any medium or in any form for any purpose, without the express written consent of BIS Research Inc. Customer will not disclose the contents of the report, whether directly in any media or indirectly through incorporation in a database, marketing list, report or otherwise, or use or permit the use of Information to generate any statistical or other information that is or will be provided to third parties; or voluntarily produce Information in legal proceedings. Market reports are based on expectations, estimates and projections as of the date such information is available. Any recommendation contained in this report may not be suitable for all investors or businesses. The market conclusions drawn are necessarily based upon a number of estimates and assumptions that, while considered reasonable by BIS Research Inc. as of the date of such statements, are inherently subject to market fluctuations and business, economic and competitive uncertainties, and contingencies For more details regarding permission, please contact us: Email: sales@bisresearch.com GLOBAL ACELLULAR THERAPY MARKET – STRATEGIES AND APPLICATIONS Tel: +1 510 404 8135 11 All rights reserved at BIS Research Inc.

  12. GLOBAL ACELLULAR THERAPY MARKET – STRATEGIES AND APPLICATIONS BIS RESEARCH INC. 39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686 E-mail: hello@bisresearch.com | Call Us: +1-510-404-8135 Global Delivery Center Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway, Sector 126, Noida, U.P., 201303, India Tel: +91 120 4261540 / 4261544 www.bisresearch.com 12 All rights reserved at BIS Research Inc.

More Related